Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Availability of drugs and resistance testing for BPaLM regimen for rifampicin-resistant tuberculosis in Europe.
Clin Microbiol Infect. 2024 Mar 13:S1198-743X(24)00121-6. doi: 10.1016/j.cmi.2024.03.009. Online ahead of print.
Clin Microbiol Infect. 2024.
PMID: 38490355
Infection control, genetic assessment of drug resistance and drug susceptibility testing in the current management of multidrug/extensively-resistant tuberculosis (M/XDR-TB) in Europe: A tuberculosis network European Trialsgroup (TBNET) study.
Bothamley GH, Lange C; TBNET.
Bothamley GH, et al.
Respir Med. 2017 Nov;132:68-75. doi: 10.1016/j.rmed.2017.09.007. Epub 2017 Sep 23.
Respir Med. 2017.
PMID: 29229108
Free article.
Item in Clipboard
Compassionate use of bedaquiline for the treatment of multidrug-resistant and extensively drug-resistant tuberculosis: interim analysis of a French cohort.
Guglielmetti L, Le Dû D, Jachym M, Henry B, Martin D, Caumes E, Veziris N, Métivier N, Robert J; MDR-TB Management Group of the French National Reference Center for Mycobacteria and the Physicians of the French MDR-TB Cohort.
Guglielmetti L, et al.
Clin Infect Dis. 2015 Jan 15;60(2):188-94. doi: 10.1093/cid/ciu786. Epub 2014 Oct 15.
Clin Infect Dis. 2015.
PMID: 25320286
Item in Clipboard
Barriers and facilitators to early access of bedaquiline and delamanid for MDR-TB: a mixed-methods study.
Rodriguez CA, Brooks MB, Guglielmetti L, Hewison C, Jachym MF, Lessem E, Varaine F, Mitnick CD.
Rodriguez CA, et al. Among authors: jachym mf.
Public Health Action. 2019 Mar 21;9(1):32-41. doi: 10.5588/pha.18.0078.
Public Health Action. 2019.
PMID: 30963040
Free PMC article.
Item in Clipboard
Isoniazid-monoresistant tuberculosis in France: Risk factors, treatment outcomes and adverse events.
Bachir M, Guglielmetti L, Tunesi S, Billard-Pomares T, Chiesi S, Jaffré J, Langris H, Pourcher V, Schramm F, Lemaître N, Robert J; Isoniazid Resistance Group.
Bachir M, et al.
Int J Infect Dis. 2021 Jun;107:86-91. doi: 10.1016/j.ijid.2021.03.093. Epub 2021 Apr 3.
Int J Infect Dis. 2021.
PMID: 33823278
Free article.
Item in Clipboard
Visualizing viable Mycobacterium tuberculosis in sputum to monitor isolation measures.
Wyplosz B, Mougari F, Al Rawi M, Baillon C, Marigot-Outtandy D, Le Dû D, Jachym M, Hervé V, Raskine L, Cambau E.
Wyplosz B, et al.
J Infect. 2017 Feb;74(2):207-210. doi: 10.1016/j.jinf.2016.11.014. Epub 2016 Dec 7.
J Infect. 2017.
PMID: 27939814
No abstract available.
Item in Clipboard
Multidrug-resistant tuberculous meningitis in an HIV-positive patient: a challenging disease.
Meybeck A, Calbet J, Ruimy R, Mashri K, Jachym M, Joly V, Yeni P.
Meybeck A, et al.
AIDS Patient Care STDS. 2007 Mar;21(3):149-53. doi: 10.1089/apc.2006.0058.
AIDS Patient Care STDS. 2007.
PMID: 17428182
Item in Clipboard
Cite
Cite